{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:46:25Z","timestamp":1786988785140,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.eplepsyres.2025.107547","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T21:56:21Z","timestamp":1743630981000},"page":"107547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Associating clinical outcomes and number of antiseizure medications in refractory status epilepticus"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9212-3955","authenticated-orcid":false,"given":"Jacob","family":"Smearman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyinna","family":"Nwachuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eplepsyres.2025.107547_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1474-4422(15)00042-3","article-title":"Status epilepticus in adults","volume":"14","author":"Betjemann","year":"2015","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit. Care"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12028-012-9711-3","article-title":"Practice variations in the management of status epilepticus","volume":"17","author":"Cook","year":"2012","journal-title":"Neurocrit. Care"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccc.2022.07.006","article-title":"Status epilepticus","volume":"39","author":"Coppler","year":"2023","journal-title":"Crit. Care Clin."},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107547_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12028-018-0513-0","article-title":"Outcomes in children treated with pentobarbital infusion for refractory and super-refractory status epilepticus","volume":"29","author":"Erklauer","year":"2018","journal-title":"Neurocrit Care"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107547_bib6","first-page":"202","article-title":"Antiepileptic and anesthetic drugs in the intensive care unit and their impact on non-convulsive status epilepticus mortality","volume":"83","author":"Ezquiaga","year":"2023","journal-title":"Medicina"},{"issue":"9","key":"10.1016\/j.eplepsyres.2025.107547_bib7","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/epi.16984","article-title":"Factors associated with long-term outcomes in pediatric refractory status epilepticus","volume":"62","author":"Ga\u00edna-Lein","year":"2021","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107547_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.25416","article-title":"Factors predicting cessation of status epilepticus in clinical practice: Data from a prospective observational registry (SENSE)","volume":"85","author":"Kellinghaus","year":"2019","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3988\/jcn.2021.17.1.11","article-title":"Antiepileptic drug therapy for status epilepticus","volume":"17","author":"Kim","year":"2021","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107547_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.seizure.2023.03.020","article-title":"Status epilepticus and benzodiazepine treatment: Use, underdosing and outcome - insights from a retrospective, multicentre registry","volume":"107","author":"Kohle","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2025.107547_bib12","unstructured":"Modified Rankin Score (mRS). Specifications manual for Joint Commission national quality measures (v2018A). Published 2018. Accessed July 23, 2023. \u3008https:\/\/manual.jointcommission.org\/releases\/TJC2018A\/DataElem0569.html\u3009."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107547_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40263-016-0389-5","article-title":"Anesthetics and outcome in status epilepticus: a matched two-center cohort study","volume":"31","author":"Sutter","year":"2017","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.eplepsyres.2025.107547_bib14","first-page":"559","article-title":"Management of status epilepticus, refractory status epilepticus, and super-refractory status epilepticus","volume":"28","author":"Trinka","year":"2022","journal-title":"Contin. (Minneap. Minn."},{"key":"10.1016\/j.eplepsyres.2025.107547_bib15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.eplepsyres.2025.107547_bib16","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:35:10Z","timestamp":1746081310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":16,"alternative-id":["S0920121125000488"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107547","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associating clinical outcomes and number of antiseizure medications in refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107547"}}